The Maryland Stem Cell Research Fund (MSCRF) is focused on identifying and fostering cutting-edge research and innovation in the field of regenerative medicine in Maryland. Our Accelerating Cures initiative comprises programs that help transition human stem cell-based technologies from the bench to the bedside as well as mechanisms to build and grow stem cell companies in Maryland. Since 2007, MSCRF has invested close to $200 million in accelerating stem cell research, cures and commercialization, in addition to building a collaborative stem cell community in our region. Discover how the Maryland Stem Cell Research Fund Accelerates Cures here.

Below is a list of our most current awardees.

Awardees

2026

Discovery
Dr. Haiqing Liu

An OASIS-Enabled Human Neuron Platform for Discovering Therapeutics Targeting Environmentally Driven a-Synuclein Pathology in Lewy Body Dementia

Discovery
Dr. Vasiliki Machairaki

Investigating Nanotube-Mediated Intercellular Communication in Human iPSC Models of Alzheimer's Disease

Discovery
Dr. Sheikh Amer Riazuddin

Personalized Treatment of Corneal Endothelial Diseases using CRISPR/Cas9-edited, Patient-specific, iPSC-derived Corneal Endothelial Cells

Discovery
Dr. Emmanouil Tampakakis

Programmable m6A Epitranscriptomic Editing to Restore MYBPC3 Function in Human iPSC Models of Hypertrophic Cardiomyopathy

Post-Doctoral Fellowship
Dr. Michael Anderson

Mentor: Dr. Gabsang Lee

Defining Genetic Regulators and Phase Transitions of -Synuclein Pathology in Human Neurons

Post-Doctoral Fellowship
Dr. Xiang Liu

Mentor: Dr.  Xizhen Lian

Multidimensional Lipid Nanoparticle Engineering for Fetal Hemoglobin Reactivation via In Vivo Base Editing in Human Hematopoietic Stem Cells

Launch
Dr. Rupali Srivastava Srivastava

Pathological CaV1.2-BK Channel Interaction in Bipolar Disorder: Mechanism-Driven Biomarker and Therapeutic Intervention

2025

Clinical
Dr. Alla Danilkovitch

A Phase 1/2a, Multicenter, Randomized, Controlled, Single-Blind, Dose-Finding Study to
Evaluate the Safety and Efficacy of BRC-OA, a Human Adipose Allograft, for Treatment of Knee
Osteoarthritis

Launch
Dr. Qun Li

Effects of Early General Anesthetic Exposure on Neural Development: An In Vitro Study Using Human Induced Pluripotent Stem Cell Derived Brain Microphysiological System

2024

Commercialization
Dr. Mandeep Singh

Agnos Therapeutics, Inc.

Development of Cellular Component Transfer (CCT) as a Treatment to Restore Vision in Retinitis Pigmentosa

Post-Doctoral Fellowship
Dr. Cristina Zivko

Mentor: Dr. Vasiliki Machairaki

MALDI-Imaging of iPSC-Derived Hindbrain Organoids as in Vitro Models for Alzheimer’s Disease and Drug Screenings

Manufacturing Assistance
Dr. Evelyn Chukwurah

Enhancement of Capabilities of Existing Cytocentric Xvivo System Model 2 from
BioSpherix

2023

2022

Discovery
Dr. Srinivasa Rao Sripathi

High-Throughput Screen For Small Molecules That Inhibit RPE-EMT as an Approach for Treatment of  AMD

Launch
Dr. Patrick Cahan

Distilling Predictive Models of Human Stem Cell Fate Control from Single Cell Omics Data

2021

Post-Doctoral Fellowship
Dr. Bo Am Seo

Mentor: Dr. Hanseok Ko

Neurotoxic Astrocyte Secreted-ExoDrp1 Causes Excessive Mitochondrial Fragmentation and Neurodegeneration of Human Dopaminergic Neurons

2020

Annual Reports

Annual reports include profiles and details on past MSCRF awardees, the MSCR Commission, and closed grant awardees.